Related Experiment Video
Updated: Jun 6, 2025

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Plant-Made Vaccines Targeting Enteric Pathogens-Safe Alternatives for Vaccination in Developing Countries
Edgar Trujillo1, Carlos Angulo1
1Immunology & Vaccinology Group. Centro de Investigaciones Biológicas del Noroeste, S.C. (CIBNOR). Instituto Politécnico Nacional 195, Playa Palo de Santa Rita Sur, La Paz, B.C.S., México.
Plant-made vaccines offer a cost-effective solution for preventing enteric diseases, especially in low-income countries. This review explores their development, challenges, and potential to overcome barriers to vaccine access.
Area of Science:
- Vaccinology
- Molecular Biology
- Global Health
Background:
- Enteric diseases are a major global health threat, particularly in low-income regions.
- Existing vaccines and treatments face challenges in accessibility and cost.
- Plant-made vaccines present a promising, potentially more affordable alternative.
Purpose of the Study:
- To review common enteric pathogens and current vaccine strategies.
- To summarize the development of plant-made vaccines for enteric diseases.
- To discuss challenges and future trends for plant-based vaccine technology.
Main Methods:
- Literature review of enteric diseases, existing vaccines, and plant-made vaccine research.
- Analysis of production costs, distribution challenges, and immunogenicity of plant-based vaccines.
- Identification of strategies to improve yields and efficacy of plant-made vaccines.
Main Results:
- Plant-made vaccines can potentially reduce production costs and eliminate cold-chain requirements.
- Prototypes for plant-based enteric vaccines show promise but face challenges in yield and immunogenicity.
- Ongoing research focuses on optimizing expression systems and delivery methods.
Conclusions:
- Plant-made vaccines are a viable strategy to improve access to enteric disease prevention in underserved populations.
- Overcoming challenges in yield and immunogenicity is crucial for clinical success.
- Further development is needed to realize the potential of plant-based vaccines for global health impact.
More Related Videos
05:33Author Spotlight: Optimizing Apoplast Protein Extraction for Efficient Recovery of Recombinant Proteins from Plant Cells
Published on: July 5, 2024
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Vaccinations
Cross-reactivity